...
首页> 外文期刊>Journal of cardiovascular translational research >Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease
【24h】

Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease

机译:鉴定 miR-143 是人类狭窄性主动脉瓣疾病的主要贡献者

获取原文
获取原文并翻译 | 示例

摘要

Calcification of aortic valves leads to aortic stenosis mainly in elderly individuals, but the underlying molecular mechanisms are still not understood. Here, we studied microRNA (miR, miRNA) expression and function in healthy and stenotic human aortic valves. We identified miR-21, miR-24, and miR-143 to be highly upregulated in stenotic aortic valves. Using luciferase reporter systems, we found direct binding of miR-143 to the 3'UTR region of the matrix gla protein (MGP), which in turn is a key factor to sustain homeostasis in aortic valves. In subsequent experiments, we demonstrated a therapeutic potential of miRNA regulation during calcification in cardiac valvular interstitial cells. Collectively, our data provide evidence that deregulated miR expression contributes to the development of stenotic valve disease and thus form novel therapeutic opportunities of this severe cardiovascular disease.
机译:主动脉瓣钙化主要导致老年人主动脉瓣狭窄,但其潜在的分子机制尚不清楚。在这里,我们研究了microRNA(miR,miRNA)在健康和狭窄的人主动脉瓣中的表达和功能。我们发现 miR-21、miR-24 和 miR-143 在狭窄主动脉瓣中高度上调。使用荧光素酶报告系统,我们发现 miR-143 与基质 gla 蛋白 (MGP) 的 3'UTR 区域直接结合,这反过来又是维持主动脉瓣稳态的关键因素。在随后的实验中,我们证明了心脏瓣膜间质细胞钙化过程中miRNA调节的治疗潜力。总的来说,我们的数据提供了证据,证明失调的miR表达有助于狭窄瓣膜疾病的发展,从而为这种严重的心血管疾病提供了新的治疗机会。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号